1975
DOI: 10.1159/000214094
|View full text |Cite
|
Sign up to set email alerts
|

Fibrin Plate Method with Reagents Purified by Affinity Chromatography and its Use for Determination of Fibrinolytic and Other Proteolytic Activity in Saliva, Bile and Plasma

Abstract: A modification of the fibrin plate method is presented. Plasminogen-free human fibrinogen and plasminogen purified by affinity chromatography have been used. Fibrin plates without and with a constant amount of plasminogen and with agarose as stabilizing medium were used for the estimation of plasmin and plasminogen activator activity. Activator activity could be demonstrated in sterile bile and saliva. When plasmin activity was present, estimations of plasminogen activator were approximate. The method is sensi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

1980
1980
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 14 publications
0
17
0
Order By: Relevance
“…Fibrinolytic Activity Preparation of the fibrin plate (Modified Noren Methods) 16) : A 0.3% fibrinogen solution (5 ml) was added to 5 ml of 1% agarose solution, then 0.1 ml of 100 IU/ml thrombin was added to this mixture with or without plasminogen.…”
Section: General Proceduresmentioning
confidence: 99%
“…Fibrinolytic Activity Preparation of the fibrin plate (Modified Noren Methods) 16) : A 0.3% fibrinogen solution (5 ml) was added to 5 ml of 1% agarose solution, then 0.1 ml of 100 IU/ml thrombin was added to this mixture with or without plasminogen.…”
Section: General Proceduresmentioning
confidence: 99%
“…(0-37 (0-07) vs 0-56 (0 06) PU, p < 0-05). The Analysis of individual data on male patients significantly lower plasminogen activator capacity in showed that 17% had values of factor VIII above female patients compared with that in female con-the 90th percentile of matched controls, 22% had (n = 20) (n = 12) (n = 68) Fibrinogen (g/l) [3][4][5][6][7][8][9][10][11][12][13][14][15][16] ( values of von Willebrand factor above the 90th percentile, and 37-5% had values of the fast inhibitor of tissue plasminogen activator about the 90th percentile (values above 135% for factor VIII, 150% for von Willebrand factor, and 3-5 AU/ml for the fast inhibitor of tissue plasminogen activator). Similar analysis of plasminogen activator capacity data showed that 20-8% of male patients had values below the 10th percentile of control subjects (values below 0-15).…”
Section: Clinical Characteristics and Risk Indicatorsmentioning
confidence: 99%
“…16 Protein C concentration was determined using an enzyme-linked immunosorbent assay (ELISA) method using reagents from Boehringer Mannheim, Mannheim, Germany. 17 Tissue plasminogen activator (tPA) activity was determined by a fibrin plate method, 18 and tPA capacity was measured as the difference in tPA activity before and after 10 minutes of venous stasis at 100 mm Hg (between the systolic and diastolic blood pressures).…”
mentioning
confidence: 99%